Brokerages expect National Health Investors, Inc. (NYSE:NHI) to report sales of $71.36 million for the current quarter, Zacks Investment Research reports. Two analysts have issued estimates for National Health Investors’ earnings, with estimates ranging from $70.90 million to $71.83 million. National Health Investors posted sales of $64.69 million during the same quarter last year, which would indicate a positive year over year growth rate of 10.3%. The firm is scheduled to issue its next quarterly earnings report on Friday, February 16th.

According to Zacks, analysts expect that National Health Investors will report full year sales of $71.36 million for the current year, with estimates ranging from $275.00 million to $279.03 million. For the next year, analysts expect that the business will report sales of $300.42 million per share, with estimates ranging from $298.19 million to $303.08 million. Zacks Investment Research’s sales averages are a mean average based on a survey of analysts that cover National Health Investors.

A number of analysts have recently issued reports on NHI shares. Capital One Financial assumed coverage on shares of National Health Investors in a research note on Monday, October 23rd. They issued an “equal weight” rating for the company. Zacks Investment Research raised shares of National Health Investors from a “hold” rating to a “buy” rating and set a $89.00 target price on the stock in a research report on Friday, September 15th. KeyCorp reiterated a “hold” rating on shares of National Health Investors in a research note on Sunday, September 17th. Stifel Nicolaus reaffirmed a “buy” rating and set a $82.00 price target on shares of National Health Investors in a report on Wednesday, October 4th. Finally, SunTrust Banks assumed coverage on National Health Investors in a report on Tuesday, October 10th. They set a “hold” rating and a $80.00 price target for the company. One equities research analyst has rated the stock with a sell rating, eight have assigned a hold rating and two have assigned a buy rating to the company’s stock. The stock currently has a consensus rating of “Hold” and an average target price of $80.14.

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Prudential Financial Inc. lifted its holdings in National Health Investors by 137.4% in the second quarter. Prudential Financial Inc. now owns 13,683 shares of the real estate investment trust’s stock valued at $1,084,000 after acquiring an additional 7,920 shares during the period. Tocqueville Asset Management L.P. increased its holdings in National Health Investors by 2.3% during the 2nd quarter. Tocqueville Asset Management L.P. now owns 4,400 shares of the real estate investment trust’s stock valued at $348,000 after purchasing an additional 100 shares in the last quarter. Good Life Advisors LLC bought a new position in National Health Investors in the 2nd quarter valued at $282,000. Dupont Capital Management Corp bought a new position in National Health Investors in the 3rd quarter valued at $2,087,000. Finally, Legal & General Group Plc boosted its position in shares of National Health Investors by 12.8% in the 2nd quarter. Legal & General Group Plc now owns 102,004 shares of the real estate investment trust’s stock worth $8,077,000 after purchasing an additional 11,556 shares during the last quarter. 70.65% of the stock is owned by hedge funds and other institutional investors.

Shares of National Health Investors (NYSE NHI) opened at $78.00 on Friday. The company has a quick ratio of 12.72, a current ratio of 12.72 and a debt-to-equity ratio of 0.84. National Health Investors has a 12-month low of $68.75 and a 12-month high of $81.21. The stock has a market capitalization of $3,240.00, a PE ratio of 15.03, a P/E/G ratio of 3.84 and a beta of 0.58.

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 31st. Shareholders of record on Friday, December 29th will be given a $0.95 dividend. The ex-dividend date is Thursday, December 28th. This represents a $3.80 dividend on an annualized basis and a yield of 4.87%. National Health Investors’s payout ratio is 95.00%.

WARNING: “Zacks: Analysts Anticipate National Health Investors, Inc. (NHI) Will Announce Quarterly Sales of $71.36 Million” was posted by American Banking News and is the property of of American Banking News. If you are accessing this report on another publication, it was illegally stolen and republished in violation of United States & international copyright law. The correct version of this report can be accessed at https://www.americanbankingnews.com/2017/12/01/zacks-analysts-anticipate-national-health-investors-inc-nhi-will-announce-quarterly-sales-of-71-36-million.html.

About National Health Investors

National Health Investors, Inc is a self-managed real estate investment trust (REIT) specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. The Company is engaged in the business of owning and financing healthcare properties.

Get a free copy of the Zacks research report on National Health Investors (NHI)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for National Health Investors (NYSE:NHI)

Receive News & Ratings for National Health Investors Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors Inc. and related companies with MarketBeat.com's FREE daily email newsletter.